EyePoint Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
17.06.25
/
50%
€8.18
Target price
17.06.26
€24.24
Performance (%)
14.33%
Price
12.08.25
€8.70
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 14.33%. This prediction currently runs until 17.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | 0.570% | 0.570% |
iShares Core DAX® | 1.061% | -0.453% |
iShares Nasdaq 100 | 2.615% | 4.747% |
iShares Nikkei 225® | 5.693% | 9.002% |
iShares S&P 500 | 1.433% | 3.156% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $28.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat